Summary
Recent clinical observations support the hypothesis that persistent parvovirus B19 is a triggering factor of rheumatoid arthritis (RA) in certain genetically predisposed individuals. If this hypothesis is correct, a number of RA patients may exhibit parvovirus B19 DNA in their synovial membranes. We tested the synovial tissue and peripheral blood leukocytes of 20 patients with RA, 24 patients with other arthritides or osteoarthritis (non-RA), and 34 healthy blood donors for the presence of parvovirus B19 DNA using specific DNA amplification by polymerase chain reaction (PCR). Using this technique, parvovirus B19 DNA was demonstrated in the synovial biopsies of 75% of patients with RA but in those of only 16.7% of patients with non-RA. In autologous peripheral blood mononuclear cells the percentage of PCR-positive patients was about 15% in both RA and non-RA groups and did not differ from that in healthy controls. When the PCR data were correlated with the presence of anti-parvovirus B19 IgG antibodies in serum and synovia all patients with parvovirus B19 DNA in peripheral blood alone or in both peripheral blood and synovial membrane were seropositive. In contrast, about 40% of patients with parvovirus B19 DNA restricted to the synovial membrane were seronegative. These data indicate a highly disease-related persistence of parvovirus B19 in the rheumatoid synovium.
Article PDF
Similar content being viewed by others
References
Pattison JR (1990) Parvoviruses. In: Fields N, Knipe DM (eds) Virology. Raven, New York
Kurtzman GJ, Cohen BJ, Field HM et al (1989) Immune respone to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 84:1114–1123
White DG, Woolf AD, Mortimer PP et al (1985) Human parvovirus arthropathy. Lancet I:419–421
Reid DM, Reid TMS, Brown T et al (1985) Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet I:422–425
Cohen BJ, Buckley MM, Clewley JP et al (1986) Human parvovirus infection in an early rheumatoid and inflammatory arthritis. Ann Rheum Dis 45:832–838
Naides SJ, Scharosch CC, Foto T et al (1990) Rheumatologic manifestations of human parvovirus B19 infection in adults. Arthritis Rheum 33:1297–1309
Arnett FC, Edworth SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Frickhofen N, Young NS (1989) Persistent parvovirus B19 infections in humans. Microb Pathog 7:319–327
Koch WC, Adler SP (1990) Detection of human parvovirus B19 DNA by using the polymerase chain reaction. J. Clin Microbiol 28:65–69
Sevall JS (1990) Detection of parvovirus B19 by dot blot and polymerase chain reaction. Mol Cell Probes 4:237–246
Hassam S, Briner J, Tratschin JD et al (1990) In situ hybridization for the detection of human parvovirus B19 nucleic acid sequence in paraffin embedded specimens. virchows Arch [B] 59:257–261
Einsele H, Vallbracht A, Kandolf R et al (1989) Hybridization techniques provide improved sensitivity for HCMV detection and allow quantitation of the virus in clinical specimens. J Virol Methods 26:91–93
Permeen A, Sam CK, Pathmanthan R et al (1990) Detection of Epstein-Barr virus DNA in nasopharyngeal carcinoma using a non-radioactive digoxigenin-labelled probe. J Virol Methods 27:261
Einsele H, Steidle M, Vallbracht A et al (1991) Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood 77:1104–1110
Schwarz TF, Roggendorf M, Suschke H et al (1987) Human parvovirus B19 infection and juvenile chronic polyarthritis. Infection 15:264–265
Klouda PT, Corbin SA, Bradley BA et al (1986) HLA and acute arthritis following human parvovirus infection. Tissue Antigens 28: 318–319
Woolf AD, Campion GV, Klouda P et al (1986) HLA and the clinical manifestation of human parvovirus infection. Br J Rheumatol 25 [Suppl 1]:35
Dijkmans BAC, Breedveld FC, Vries RRP de (1986) HLA antigens in human parvovirus arthropathy. J Rheumatol 13:1192–1193
Simpson RW, McGinty L, Simon L et al (1984) Association of parvoviruses with rheumatoid arthritis of humans. Science 223:1425–1428
Naides SJ, Foto F, Scharosch LL et al (1991) Detection of parvovirus B19-specific DNA sequences in bone marrow aspirates from chronic B19 arthropathy patients. Cell Biochem 45 [suppl 15E]:157
Dijkmans BAC, Elsacker-Niele AMW van, Salimans MMM et al (1988) Human parvovirus B19 DNA in synovial fluid. Arthritis Rheum 31:279–281
Salimans MMM, Holsappel S, Rijke FM van et al (1989) Rapid detection of human parvovirus B19 DNA by dot blot hybridization and the polymerase chain reaction. J Virol Methods 23:19–28
Clewley JP (1989) Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol 27:2647–2651
Srivastava A, Bruno E, Briddell R et al (1990) Parvovirus B19 induced perturbation of human megakaryo-cytopoiesis in vitro. Blood 76:1997–2004
Lefrere JJ, Meyer O, Menkes CJ et al (1985) Human parvovirus and rheumatoid arthritis. Lancet I:982
Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662
Fritz P, Laschner W, Saal JG et al (1989) Histological classification of synovitis. Zentralbl Allg Pathol 135:729–741
Shade RO, Blundell MC, Cotmore SA et al (1986) Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 58:921–936
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saal, J.G., Steidle, M., Einsele, H. et al. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int 12, 147–151 (1992). https://doi.org/10.1007/BF00274934
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00274934